Viewing Study NCT02624557


Ignite Creation Date: 2025-12-24 @ 7:00 PM
Ignite Modification Date: 2026-02-20 @ 11:01 AM
Study NCT ID: NCT02624557
Status: COMPLETED
Last Update Posted: 2020-12-09
First Post: 2015-12-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacokinetic Study of Alpelisib in Subjects With Hepatic Impairment.
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatic Impairment View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hepatic impairment View
None Healthy volunteers View
None Clinical pharmacology study View
None BYL719 View
None alpelisib View